UnitedHealthcare Pharmacy
Clinical Pharmacy Programs
Program Number 2024 P 1240-8
Program Prior Authorization/Notification
Medication Hemlibra® (emicizumab-kxwh)
P&T Approval Date 2/2018, 11/2018, 11/2019, 11/2020, 11/2021, 11/2022, 11/2023,
11/2024
Effective Date 2/1/2025
1. Background:
Hemlibra (emicizumab-kxwh) is a bispecific factor IXa- and factor X-directed antibody indicated
for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and
pediatric patients ages newborn and older with hemophilia A (congenital factor VIII deficiency)
with or without factor VIII inhibitors.
2. Coverage Criteriaa:
A. Hemophilia A
1. Initial Authorization
a. Hemlibra will be approved based on both of the following criteria
(1) Diagnosis of hemophilia A
-AND-
(2) Prescribed for the prevention of bleeding episodes (i.e., routine prophylaxis)
Authorization of therapy will be issued for 12 months.
2. Reauthorization
a. Documentation of positive clinical response to Hemlibra therapy
Authorization will be issued for 12 months.
a State mandates may apply. Any federal regulatory requirements and the member specific
benefit plan coverage may also impact coverage criteria. Other policies and utilization
management programs may apply.
3. Additional Clinical Rules:
• Notwithstanding Coverage Criteria, UnitedHealthcare may approve initial and re-authorization
based solely on previous claim/medication history, diagnosis codes (ICD-10) and/or claim logic.
Use of automated approval and re-approval processes varies by program and/or therapeutic class.
• Medical Necessity may be in place
© 2024 UnitedHealthcare Services Inc.
1
4. References:
1. Hemlibra® [package insert]. South San Francisco, CA: Genentech, Inc.; January 2024.
Program Prior Authorization/Notification - Hemlibra (emicizumab-kxwh)
Change Control
2/2018 New program
11/2018 Updated program to align with new labeled indication in patients with
hemophilia A without inhibitors. Updated references.
11/2019 Annual review. No changes to clinical coverage criteria. Updated
reference.
11/2020 Annual review. Updated references.
11/2021 Annual review with no changes to clinical coverage criteria. Updated
reference.
11/2022 Annual review with no changes to clinical coverage criteria. Updated
reference and added state mandate footnote.
11/2023 Annual review with no changes to clinical coverage criteria. Updated
reference.
11/2024 Annual review with no changes to clinical coverage criteria. Updated
reference.
© 2024 UnitedHealthcare Services Inc.
2